Investing
218 Articles
ThinkstockS&P 500 dividend growth continues to outpace earnings growth, a trend that likely will continue for a few more years.…
thinkstockPMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell Inc. (NASDAQ: DELL)…
ThinkstockDrug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday.…
The three major US stock indexes opened lower this morning following a negative reaction by a government official to a…
Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls…
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp.…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…
The three major US stock indexes opened sharply lower this morning following a tepid report on US job growth. The…
Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…
The major US stock indexes opened flat this morning but started to move higher following the better-than-expected ISM report on…
Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord also reiterated its buy rating…
Our top personal finance-related articles today. Your wallet will thank you later.